These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7845323)

  • 21. Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats.
    Atessahin A; Yilmaz S; Karahan I; Ceribasi AO; Karaoglu A
    Toxicology; 2005 Sep; 212(2-3):116-23. PubMed ID: 15946783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection by ozone preconditioning is mediated by the antioxidant system in cisplatin-induced nephrotoxicity in rats.
    Borrego A; Zamora ZB; González R; Romay C; Menéndez S; Hernández F; Montero T; Rojas E
    Mediators Inflamm; 2004 Feb; 13(1):13-9. PubMed ID: 15203559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential nephrotoxicity of intravenous infusions of naftidrofuryl oxalate.
    Le Meur Y; Moesch C; Rincé M; Aldigier JC; Leroux-Robert C
    Nephrol Dial Transplant; 1995; 10(9):1751-5. PubMed ID: 8559500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity.
    Chirino YI; Sánchez-González DJ; Martínez-Martínez CM; Cruz C; Pedraza-Chaverri J
    Toxicology; 2008 Mar; 245(1-2):18-23. PubMed ID: 18243469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin C attenuates cisplatin-induced alterations in renal brush border membrane enzymes and phosphate transport.
    Fatima S; Arivarasu NA; Mahmood R
    Hum Exp Toxicol; 2007 May; 26(5):419-26. PubMed ID: 17623766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats.
    Ozen S; Akyol O; Iraz M; Söğüt S; Ozuğurlu F; Ozyurt H; Odaci E; Yildirim Z
    J Appl Toxicol; 2004; 24(1):27-35. PubMed ID: 14745844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of cisplatin-induced nephrotoxicity by glucosides of ascorbic acid and alpha-tocopherol.
    Maliakel DM; Kagiya TV; Nair CK
    Exp Toxicol Pathol; 2008 Sep; 60(6):521-7. PubMed ID: 18644706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: laboratory and clinical aspects.
    Capizzi RL
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):72-81. PubMed ID: 10348264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lycopene, a carotenoid, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rats.
    Ateşşahin A; Ceribaşi AO; Yilmaz S
    Basic Clin Pharmacol Toxicol; 2007 Jun; 100(6):372-6. PubMed ID: 17516989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
    Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
    Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
    Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adriamycin-induced cardiomyopathy aggravated by cis-platinum nephrotoxicity requiring dialysis.
    Tay HN; Yap HK; Murugasu B; Quah TC; Tay SH; Lim JW
    J Singapore Paediatr Soc; 1990; 32(3-4):125-8. PubMed ID: 1966850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin-induced nephrotoxicity.
    Meijer S; Sleijfer DT; Mulder NH; Donker AJ
    Neth J Med; 1982; 25(8):262-9. PubMed ID: 6755283
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful continuation of cisplatin therapy after partial recovery from acute renal failure.
    Wong DC; Deisseroth AB
    Cancer Treat Rep; 1985 Jun; 69(6):731-3. PubMed ID: 4040425
    [No Abstract]   [Full Text] [Related]  

  • 35. Cisplatin-induced massive renal tubular failure with wastage of serum electrolytes.
    Bjornson DC; Stephenson SR
    Clin Pharm; 1983; 2(1):80-3. PubMed ID: 6684013
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acute renal failure after the use of cis-diamminedichloroplatinum, gentamycin and cephalosporins].
    Leite JB; Gentil Fde C; Burchenal J; Marques A; Teixeira MI; Abrão FS
    Rev Paul Med; 1981; 97(4-6):75-7. PubMed ID: 7199754
    [No Abstract]   [Full Text] [Related]  

  • 37. Life-threatening hypocalcemia and hypomagnesemia associated with cisplatin chemotherapy.
    Gonzalez C; Villasanta U
    Obstet Gynecol; 1982 Jun; 59(6):732-4. PubMed ID: 7200596
    [No Abstract]   [Full Text] [Related]  

  • 38. Hemolytic uremic syndrome associated with cisplatin therapy.
    Weinblatt ME; Kahn E; Scimeca PG; Kochen JA
    Am J Pediatr Hematol Oncol; 1987; 9(4):295-8. PubMed ID: 3439578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thoracic malignancies, cisplatin and renal function.
    Nortier J; Sculier JP
    Eur Respir J; 2011 Apr; 37(4):760-1. PubMed ID: 21454897
    [No Abstract]   [Full Text] [Related]  

  • 40. Nephrotoxicity of demethylchlortetracycline hydrochloride. A prospective study.
    Roth H; Becker KL; Shalhoub RJ; Katz S
    Arch Intern Med; 1967 Oct; 120(4):433-5. PubMed ID: 4964507
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.